Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration
- 13 April 2004
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 153 (2) , 367-376
- https://doi.org/10.1016/j.bbr.2003.12.026
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Role of excitatory amino acids in developmental epilepsiesMental Retardation and Developmental Disabilities Research Reviews, 2001
- Glutamate signaling and the fetal alcohol syndromeMental Retardation and Developmental Disabilities Research Reviews, 2001
- Ethanol-Induced Apoptotic Neurodegeneration and Fetal Alcohol SyndromeScience, 2000
- Involvement of Activated Caspase‐3‐Like Proteases in N‐Methyl‐D‐Aspartate‐Induced Apoptosis in Cerebrocortical NeuronsJournal of Neurochemistry, 2000
- Neurobiological Bases of Behavioral Development in the First YearNeuropediatrics, 1997
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- Glutamate, a Neurotoxic TransmitterJournal of Child Neurology, 1989
- Gas Exchange during Xylazine–ketamine Anesthesia in Neonatal CalvesVeterinary Surgery, 1988
- Spatial memory and hippocampal functionNeuropsychologia, 1979
- Neonatal Neurobehavioral Tests Following Vaginal Delivery Under Ketamine, Thiopental, and Extradural AnesthesiaAnesthesia & Analgesia, 1977